Literature DB >> 14655604

[Reiter syndrome after intravesical Bacillus Calmette-Guerin (BCG) immunotherapy: a case report].

Masahiro Shiba1, Takahiro Fujii, Hiroshi Takatera.   

Abstract

A 56-year-old man who had previously undergone transurethral resection and intra-arterial chemotherapy for bladder cancer developed irritable bladder, bilateral conjunctivitis and arthritis including the knees, ankles and sacroiliac joints after starting intravesical Calmette-Guerin bacillus (BCG) immunotherapy. These symptoms were in agreement with the features of Reiter syndrome. One month after cessation of the intravesical BCG immunotherapy and initiation of the treatment with a non-steroidal anti-inflammatory drug (NSAID), he was not complaining of symptoms. Reiter syndrome is an uncommon complication after intravesical BCG immunotherapy. Nevertheless, since the prolonged arthritis has a possibility to cause joint deformity, we must pay serious attention to this side effect.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14655604

Source DB:  PubMed          Journal:  Hinyokika Kiyo        ISSN: 0018-1994


  2 in total

Review 1.  Reactive arthritis following BCG immunotherapy for urinary bladder carcinoma: a systematic review.

Authors:  Elisa Tinazzi; Vincenzo Ficarra; Sara Simeoni; Walter Artibani; Claudio Lunardi
Journal:  Rheumatol Int       Date:  2005-10-12       Impact factor: 2.631

2.  Systemic BCG-Osis as a Rare Side Effect of Intravesical BCG Treatment for Superficial Bladder Cancer.

Authors:  S Lukacs; B Tschobotko; N A Szabo; Andrew Symes
Journal:  Case Rep Urol       Date:  2013-06-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.